Xtant Medical Holdings Inc (NYSE American:XTNT)

7.15
Delayed Data
As of Apr 26
 -0.10 / -1.38%
Today’s Change
3.96
Today|||52-Week Range
14.52
+4.08%
Year-to-Date
No recent news for Xtant Medical Holdings Inc.

Today’s Trading

Previous close7.25
Today’s open7.20
Day’s range7.10 - 7.39
Volume8,611
Average volume (3 months)55,896
Market cap$11.2M
Data as of 8:00pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-541.67%
Earnings growth (this year)+41.72%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+51.66%
P/E ratioNM
Price/Sales0.08
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RXIIRxi Pharmaceuticals ...+0.01+0.38%
NDRAENDRA Life Sciences ...+0.02+0.89%
CURNeuralstem Inc-0.03-1.81%
GENEGenetic Technologies...0.000.00%
Data as of 4:00pm ET, 04/26/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$90.0M
Annual profit (last year)-$19.5M
Net profit margin-21.66%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Carl D. O'Connell
Vice President-Product Development &
Operations
Anthony DeFalco
Corporate headquarters
Belgrade, Montana

Forecasts